Four leading health insurance startups all reported revenue growth through 2021's second quarter, but also suffered net losses.
Payer
Excellus BlueCross BlueShield joins the ranks of six Blue Cross Blue Shield affiliates who are refusing to cover Aduhelm, Biogen's Alzehimer's drug, without definite proof of its effectiveness.
Washington, D.C., continues to navigate discussions about giving Medicare the ability to negotiate drug prices, but analysts already foresee long-term savings for Part D premiums should it be approved.
Clover Health nearly doubled revenue in 2021's second quarter, but simultaneously saw a significant dip in net income, according to an earnings report released Aug. 11.
Kaiser Permanente's contract with Palm Springs, Calif.-based Desert Care Network ends between Aug. 30 and Oct. 1.
UnitedHealthcare and UnitedHealthcare Insurance Co. are paying $15.6 million in settlement and penalty fees after litigation and investigations by the U.S. Department of Labor and New York Attorney General.
Omaha, Neb.-based distributor Senior Market Sales claimed nearly 350 Walgreens storefronts where agents can sell health plans alongside SeekMedicare agents, according to ThinkAdvisor.
Kansas' Department of Health and Environment erroneously paid about $1.3 million to Medicaid contractors for recipients who were dead.
Manny Lopes, CEO of East Boston Neighborhood Health Center, is leaving his role to join Blue Cross Blue Shield of Massachusetts.
The coronavirus pandemic created a lag in regular healthcare for members, and while the world is recovering, the top priority for Talya Schwartz, PhD, CEO of MetroPlus Health Plan in New York City, is to plug members back into care.
